FdaApplication
ANDA 216749
Identifiers
- fda_app_no: ANDA216749
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT III |
| application_type | ANDA |
| approval_date | 2023-10-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXCARBAZEPINE | OXCARBAZEPINE | 300MG/5ML | SUSPENSION;ORAL |
1 product